afm-24
affimed
['afm24', 'nsclc', 'sclc', 'affimed']
today affimed provided details on the afm24-101 monotherapy study in nsclc at asco 2023 and provides a strategic update on the afm24 development plan. for further details, see the full press release at: #afmd #afm24 #immunooncology
We are a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer.